MicroRNAs and Renal Cell Carcinoma

RÉDOVÁ, Martina, Jaroslav MICHÁLEK and Ondřej SLABÝ. MicroRNAs and Renal Cell Carcinoma. In Ondrej Slaby. MicroRNAs in Solid Cancer: From Biomarkers to Therapeutic Targets. New York: Nova Science Publishers, Inc., 2012, p. 121-128. ISBN 978-1-61324-514-9.

Basic information

Original name

MicroRNAs and Renal Cell Carcinoma

Authors

RÉDOVÁ, Martina (203 Czech Republic, guarantor, belonging to the institution), Jaroslav MICHÁLEK (203 Czech Republic) and Ondřej SLABÝ (203 Czech Republic, belonging to the institution)

Edition

New York, MicroRNAs in Solid Cancer: From Biomarkers to Therapeutic Targets, p. 121-128, 8 pp. 2012

Publisher

Nova Science Publishers, Inc.

---

Other information

Language

English

Type of outcome

Kapitola resp. kapitoly v odborné knize

Field of Study

30200 3.2 Clinical medicine

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Publication form

printed version "print"

RIV identification code

RIV/00216224:14740/12:00060173

Organization unit

Central European Institute of Technology

ISBN

978-1-61324-514-9

Keywords in English

microRNAs; renal cell carcinoma

Tags

ok, rivok

Tags

International impact, Reviewed

---

Abstract

V originále

Renal cell carcinoma (RCC) is the most common neoplasm of the adult kidney accounting for about 3 % of adult malignancies. As the role of miRNAs in RCC pathogenesis is emerging, it has been postulated that miRNAs can serve as new potential biomarkers that may improve diagnostic, prognostic and predictive abilities, and consequently, the management of RCC patients.

---

Links

ED1.1.00/02.0068, research and development project

Name: CEITEC - central european institute of technology